The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 2×
“RANKL knock-out mice present a severe osteopetrosis and a total loss of osteoclasts [7].”
BackgroundA metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“[75] have demonstrated that TNF- acts directly on osteoclast precursors to potentiate RANKL-induced osteoclastogenesis, even in the absence of elevated levels of RANKL.”
BackgroundKobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
The interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783 · cited 2×
“IL-1, which is a pleiotropic cytokine, induces the expression of a large variety of proinflammatory molecules [45] and hematopoietic cytokines such as leukaemia inhibitory factor (LIF) and IL-6.”
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., & Kudo, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4858 · Cited by 731
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Thomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 536
Zhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu-Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 498
Palmqvist, P., Persson, E., Conaway, H. H., & Lerner, U. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3353 · Cited by 486
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/s8756-3282(02)00915-8 · Cited by 477
Baud, V., Liu, Z.-G., Bennett, B., Suzuki, N., Xia, Y., & Karin, M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1297 · Cited by 464
Zhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452
Terpos, E., Szydlo, R., Apperley, J. F., Hatjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J. M., & Rahemtulla, A. (2003) · Blood · doi:10.1182/blood-2003-02-0380 · Cited by 410
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1461 · Cited by 409
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 399
Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts
Lee, Z. H., & Kim, H.-H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00695-8 · Cited by 381
Ishida, N., Hayashi, K., Hoshijima, M., Ogawa, T., Koga, S., Miyatake, Y., Kumegawa, M., Kimura, T., & Takeya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205063200 · Cited by 377
Fuller, K., Murphy, C., Kirstein, B., Fox, S. W., & Chambers, T. J. (2002) · Endocrinology · doi:10.1210/endo.143.3.8701 · Cited by 335
Hotokezaka, H., Sakai, E., Kanaoka, K., Saito, K., Matsuo, K.-I., Kitaura, H., Yoshida, N., & Nakayama, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208284200 · Cited by 316
Li, X. (2002) · Endocrinology · doi:10.1210/en.143.8.3105 · Cited by 288
Grimaud, E., Soubigou, L., Couillaud, S., Coipeau, P., Moreau, A., Passuti, N., Gouin, F., Redini, F., & Heymann, D. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63560-2 · Cited by 282
Tan, K. B., Harrop, J., Reddy, M., Young, P., Terrett, J., Emery, J., Moore, G., & Truneh, A. (1997) · Gene · doi:10.1016/s0378-1119(97)00509-x · Cited by 277
Tumor necrosis factor alpha -induced activation of c-jun N-terminal kinase is mediated by TRAF2
Reinhard, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1080 · Cited by 276
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Armstrong, A. P., Tometsko, M. E., Glaccum, M., Sutherland, C. L., Cosman, D., & Dougall, W. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202009200 · Cited by 249
Osteoprotegerin and RANK ligand expression in prostate cancer.
Brown, J. M., Corey, E., Lee, Z. D., True, L. D., Yun, T. J., Tondravi, M., & Vessella, R. L. (2001) · Urology · doi:10.1016/s0090-4295(00)01122-5 · Cited by 234
Proinflammatory cytokine (TNFα/IL‐1α) induction of human osteoclast formation
Kudo, O., Fujikawa, Y., Itonaga, I., Sabokbar, A., Torisu, T., & Athanasou, N. A. (2002) · The Journal of Pathology · doi:10.1002/path.1190 · Cited by 229
Role of RANKL and RANK in bone loss and arthritis
Jones, D. H., Kong, Y.-Y., & Penninger, J. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii32 · Cited by 223
How the osteoclast degrades bone
Blair, H. C. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199810)20:10<837::aid-bies9>3.0.co;2-d · Cited by 219
Ikeda, T., Kasai, M., Utsuyama, M., & Hirokawa, K. (2001) · Endocrinology · doi:10.1210/endo.142.4.8070 · Cited by 215
Tumor Necrosis Factor Receptors Types 1 and 2 Differentially Regulate Osteoclastogenesis
Abu-Amer, Y., Erdmann, J., Alexopoulou, L., Kollias, G., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61511-5 · Cited by 195
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
Lam, J., Nelson, C. A., Ross, F. P., Teitelbaum, S. L., & Fremont, D. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13890 · Cited by 194
The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis
Haynes, D. R., Crotti, T. N., Potter, A. E., Loric, M., Atkins, G. J., Howie, D. W., & Findlay, D. M. (2001) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.83b6.0830902 · Cited by 186
Mice Lacking the Type I Interleukin-1 Receptor Do Not Lose Bone Mass after Ovariectomy
Lorenzo, J. A., Naprta, A., Rao, Y., Alander, C., Glaccum, M., Widmer, M., Gronowicz, G., Kalinowski, J., & Pilbeam, C. C. (1998) · Endocrinology · doi:10.1210/endo.139.6.6128 · Cited by 185
Activation of NF-κB Is Involved in the Survival of Osteoclasts Promoted by Interleukin-1
Jimi, E., Nakamura, I., Ikebe, T., Akiyama, S., Takahashi, N., & Suda, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8799 · Cited by 185
Cappellen, D., Luong-Nguyen, N.-H., Bongiovanni, S., Grenet, O., Wanke, C., & Šuša, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200434200 · Cited by 184 · cited 2×
“[86] Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M.”
Backgroundgp130 CYTOKINE FAMILY AND BONE CELLS
Heymann, D., & Rousselle, A.-V. (2000) · Cytokine · doi:10.1006/cyto.2000.0747 · Cited by 173
Roux, S., Amazit, L., Meduri, G., Guiochon-Mantel, A., Milgrom, E., & Mariette, X. (2002) · American Journal of Clinical Pathology · doi:10.1309/bpet-f2pe-p2bd-j3p3 · Cited by 173
Bellido, T., Stahl, N., Farruggella, T. J., Borba, V, Yancopoulos, G. D., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118432 · Cited by 164
Ohsaki, Y. (1992) · Endocrinology · doi:10.1210/en.131.5.2229 · Cited by 161
Mizuno, A., Kanno, T., HOSHI, M., Shibata, O., Yano, K., Fujise, N., Kinosaki, M., Yamaguchi, K., Tsuda, E., Murakami, A., et al. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740200049 · Cited by 156
Komine, M., Kukita, A., Kukita, T., Ogata, Y., Hotokebuchi, T., & Kohashi, O. (2001) · Bone · doi:10.1016/s8756-3282(01)00420-3 · Cited by 156
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget’s disease of bone.
Menaa, C., Reddy, S. V., Kurihara, N., Maeda, H., Anderson, D., Cundy, T., Cornish, J., Singer, F. R., Bruder, J. M., & Roodman, G. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9133 · Cited by 154 · cited 2×
“[81] Menaa C, Reddy SV, Kurihara N, Maeda H, Anderson D, Cundy T, et al.”
BackgroundSerum osteoprotegerin levels in healthy controls and cancer patients.
Lipton, A., Ali, S. M., Leitzel, K., Chinchilli, V. M., Witters, L. M., Engle, L. L., Holloway, D. L., Bekker, P. J., & Dunstan, C. R. (2002) · PubMed · Cited by 145
Fuller, K., Murphy, C., Kirstein, B., Fox, S., & Chambers, T. (2002) · Endocrinology · doi:10.1210/en.143.3.1108 · Cited by 145
Zou, W., Hakim, I., Tschoep, K., Endres, S., & Bar‐Shavit, Z. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1202 · Cited by 144
Greenfield, E. M., Gornik, S. A., Horowitz, M. C., Donahue, H. J., & Shaw, S. M. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081003 · Cited by 138
Kurokouchi, K., Kambe, F., Yasukawa, K., Izumi, R., Ishiguro, N., Iwata, H., & Seo, H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.8.1290 · Cited by 136
Sabokbar, A., Kudo, O., & Athanasou, N. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(02)00106-7 · Cited by 134
Osteoclasts, macrophages, and the molecular mechanisms of bone resorption
Teitelbaum, S. L., Tondravi, M. M., & Ross, F. P. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.381 · Cited by 134
Catalytic Properties of ADAM19
Chesneau, V., Becherer, J. D., Zheng, Y., Erdjument‐Bromage, H., Tempst, P., & Blobel, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302781200 · Cited by 129
Devlin, R. D., Reddy, S. V., Savino, R., Ciliberto, G., & Roodman, G. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.393 · Cited by 126
Taguchi, Y., Yamamoto, M., Yamate, T., Lin, S., Mocharla, H., DETOGNI, P., Nakayama, N., Boyce, B. F., Abe, E., & Manolagas, S. C. (1998) · PubMed · Cited by 124
Regulation of osteoclast activity
Greenfield, E. M., Bi, Y., & Miyauchi, A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00156-3 · Cited by 119
König, A., Mühlbauer, R. C., & Fleisch, H. A. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030607 · Cited by 119
Neale, S. D., Smith, R., Wass, J. A. H., & Athanasou, N. A. (2000) · Bone · doi:10.1016/s8756-3282(00)00345-8 · Cited by 111
Linkhart, T. A., Linkhart, S. G., MacCharles, D. C., et al. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061204 · Cited by 110
Hakeda, Y., Kobayashi, Y., Yamaguchi, K., Yasuda, H., Tsuda, E., Higashio, K., Miyata, T., & Kumegawa, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9523 · Cited by 107
Hattersley, G., Dorey, E., Horton, M. A., & Chambers, T. J. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370125 · Cited by 102
Takami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J., Martin, T. J., Nagai, K., & Suda, T. (2000) · Endocrinology · doi:10.1210/endo.141.12.7852 · Cited by 100
Ragab, A. A., Nalepka, J. L., Bi, Y.-M., & Greenfield, E. (2002) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00421.2001 · Cited by 99
Michigami, T., Ihara-Watanabe, M., Yamazaki, M., & Ozono, K. (2001) · PubMed · Cited by 96
Chikatsu, N., Takeuchi, Y., Tamura, Y., Fukumoto, S., Yano, K., Tsuda, E., Ogata, E., & Fujita, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2008 · Cited by 95
Lee, Y., Schwarz, E. M., Davies, M., Jo, M., Gates, J. J., Wu, J., Zhang, X., & Lieberman, J. R. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(02)00095-5 · Cited by 94
Nagai, M., Kyakumoto, S., & Sato, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2314 · Cited by 93
Fujikawa, Y., Sabokbar, A., Neale, S. D., Itonaga, I., Torisu, T., & Athanasou, N. A. (2001) · Bone · doi:10.1016/s8756-3282(00)00453-1 · Cited by 90
Komarova, S. V., Pilkington, M. F., Weidema, A. F., Dixon, S. J., & Sims, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206421200 · Cited by 88
Goltzman, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13073 · Cited by 80
TRAF5 Functions in Both RANKL- and TNFα-Induced Osteoclastogenesis
Kanazawa, K., Azuma, Y., Nakano, H., & Kudō, A. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.3.443 · Cited by 76
Tumour cells produce receptor activator of NF-κB ligand (RANKL) in skeletal metastases
Huang, L., Cheng, Y. Y., Chow, L. T. C., Zheng, M. H., & Kumta, S. M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.11.877 · Cited by 70
Alvarez, L., Peris, P., Guañabens, N., Vidal, S., Ros, I., Pons, F., Filella, X., Monegal, A., Muñoz‐Gomez, J., & Ballesta, A. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10834 · Cited by 66
Sato, T., Selleri, C., Anderson, S. M., Young, N. S., & Maciejewski, J. P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.562704.x · Cited by 64
Xing, L., Carlson, L. M., Story, B. M., Tai, Z., Keng, P., Siebenlist, U. K., & Boyce, B. F. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.260 · Cited by 63
Ueland, T., Brixen, K., Mosekilde, L., Mosekilde, L., Flyvbjerg, A., & Bollerslev, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020977 · Cited by 61
Kaji, K., Katogi, R., Azuma, Y., Naito, A., Inoue, J., & Kudō, A. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1593 · Cited by 59
Participation of protein kinase c β in osteoclast differentiation and function
Lee, S. W., Kwak, H. B., Chung, W. J., Cheong, H., Kim, H.-H., & Lee, Z. H. (2003) · Bone · doi:10.1016/s8756-3282(02)00976-6 · Cited by 52
Torcia, M. G., Lucibello, M., Vannier, E. G., et al. (1996) · PubMed · Cited by 48
Thabard, W., Collette, M., Bataille, R., & Amiot, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580193 · Cited by 39
Sugiyama, T. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170046 · Cited by 35
Good, C. R., O’Keefe, R. J., Puzas, J. E., Schwarz, E. M., & Rosier, R. N. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10067 · Cited by 32
Osteoclasts are not the major source of interleukin-6 in mouse parietal bones
Holt, I. J., Davie, M. W. J., & Marshall, M. J. E. (1996) · Bone · doi:10.1016/8756-3282(95)00482-3 · Cited by 29
Athanasou, N. A., Quinn, J. M. W., & McGee, J. O. (1988) · PubMed · Cited by 29
Takami, M. (2000) · Endocrinology · doi:10.1210/en.141.12.4711 · Cited by 20
Cited by
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis
Wojdasiewicz, P., Poniatowski, Ł. A., & Szukiewicz, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/561459 · Cited by 1,608
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Garlet, G. P. (2010) · Journal of Dental Research · doi:10.1177/0022034510376402 · Cited by 720
Metadata
- Authors
- Steeve, K. T., Marc, P., Sandrine, T., Dominique, H., & Yannick, F.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 15
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2066521125
- Cited by
- 952
- References
- 97
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.